Clinical Trial Update: Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing oral antipsychotics with injectable antipsychotics for relapse prevention in schizophrenia and schizoaffective disorder; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-07-10